For expression of JCV agnoprotein in mammalian cells, the cDNA of JCV agnoprotein was amplified by polymerase chain reaction (PCR) using a plasmid encoding the complete JCV genome, pJC1->4pJCV [VG015, Health Science Research Resources Bank (HSRRB)] and subcloned into a pCXSN plasmid (1) which was constructed by removing myc-tag from pCMV-myc (Clontech) and adding Xho I, Sal I, and Not I recognition sites; pCXSN-FlagN (1) which was constructed by adding Flag-tag to the pCXSN plasmid at the 5' region of the Xho I site; pCXSN-MycN (1) Atwood (2, 3) . Agnoprotein with mutated viral genomes (∆Agno and RK8AA) were generated by site-directed mutagenesis as described previously (1). The cDNA of AP3D1 isoform 2 was amplified from the HEK293-derived cDNA library, and subcloned into pCMV-myc (Clontech). Successful cloning was confirmed by sequencing. Myc-tagged AP3D-Y27, AP3D-Y27N and AP3D-Y27C were amplified with pCMV-myc-AP3D1 and subcloned into the pIRESneo3 vector (Clontech). AP3D-Y27, AP3D-Y27N and AP3D-Y27C were amplified with pIRESneo3-AP3D-Y27 and subcloned into pGEX6P1 vector (GE). Successful cloning was confirmed by sequencing. The plasmid encoding ts045-VSVG-GFP (pVSVG-GFP) was a kind gift from Dr. I. Wada (4). The ts045-VSVG protein is a type I transmembrane protein that has been widely used for studying secretory membrane trafficking because it contains a mutation that leads to its reversible misfolding and retention in the ER at 40°C. The entire coding sequences of VP1 (pET15b-VP1) (5) and RK8AA mutant of agnoprotein (pET15b-His-RK8AA) were amplified by PCR and subcloned into the pET15b expression vector (Novagen) for bacterial expression. The integrities of plasmids were verified by sequencing.
In vitro synthesized agnoprotein
In vitro transcription and in vitro translation were performed using the cell-free expression system, the MembraneMax HN Protein Expression Kit (Invitrogen), according to the manufacturer's instructions. The plasmid, such as pURE2-Agnoprotein, -RK8AA mutant, -K9Q mutant and pURE2 plasmids encoding agnoprotein deletion mutants(C6, C18, and C25), which contains T7 promoter, ribosomal binding site, and terminator sequence were used as a template DNA. The entire coding sequences of wild type, K9Q mutant of JCV agnoprotein and WT BKV agnoprotein (Dunlop strain) were also subcloned into the pEXP5-CT/TOPO expression vector (Invitrogen) and used as a template DNA for expression of the C-terminal hexahistidine (6 x His) tagged agnoprotein. After 4 synthesis of recombinant proteins, the reaction mixture was subjected to SDS-PAGE analysis and immunoblotting using anti-agnoprotein antibody to confirm the expression of proteins.
GST Pull-down assay
GST fusion proteins of AP3D-Y27 or its deletion mutants were expressed in E. coli (BL21DE3, Novagen) and purified with the use of glutathione-sepharose 4B beads (GE Healthcare). For in vitro GST precipitation assays, GST or GST fusion proteins were mixed with 10 µl of 50% (v/v) glutathione-sepharose 4B for 2 h at 4°C. After addition of cell lysates from 293T cells transfected with pCMV-Agno or in vitro synthesized agnoprotein in TN-TNE buffer [20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM EDTA, 1% Nonidet P-40, 1% Triton X-100, 10% glycerol, and 0.5 mM phenylmethylsulfonyl fluoride (PMSF)] and complete protease inhibitor cocktail, the mixture was incubated for another 30 min at 4°C. The beads were separated by centrifugation and washed with TN-TNE buffer, and the bound proteins were subjected to immunoblot analysis.
Preparation and Infection of Recombinant Lentiviruses
The following constructs were kindly provided by Dr. H. Miyoshi: CSII-CMV-MCS-IRES2-Bsd, a self-inactivating lentiviral construct (9); pCAG-HIVgp, a packaging construct expressing Gag and Pol proteins; and pCMV-VSV-G-RSV-Rev, a construct expressing the vesicular stomatitis virus G glycoprotein (VSV-G) and Rev. This lentiviral system is designed to express a desired gene under the direction of the CMV promoter, and the Blastcidin resistance gene as a marker for selection of 5 infected cells. Recombinant lentiviruses constitutively expressing agnoprotein were produced as follows: cDNAs encoding agnoprotein were inserted into the multicloning site of the lentiviral expression vector. The lentiviruses were prepared as previously described (10) . Briefly, 293T cells were co-transfected with three plasmids: CSII-CMV-MCS-IRES2-Bsd with or without agnoprotein cDNA insert, pCAG-HIVgp and pCMV-VSV-G-RSV-Rev using LipofectAmine 2000 (Invitrogen). The culture supernatants containing the recombinant lentiviruses were collected at 48 h after transfection, passed through a 0.45 µm filter, and used for infection experiments. SVG-A cells or 293T cells seeded in the 35-mm dishes were infected at 10% confluence with each recombinant virus.
Virus-infected cells were selected by culturing with blastcidin (10 µg/ml) containing media.
Flow Cytometry
Cells were detached using an enzyme-free/phosphate buffered saline (PBS)- AACCGACUCCUAACCUAUAAGAUCC -3'. The negative control siRNAs were previously used (11, 12) . We also used medium GC duplex siRNA (siRNA-NC3), which does not have homology to any vertebrate transcriptome (Invitrogen). The stealth RNA duplexes against AP2M, AP2M1 Stealth Select 3 RNAi (HSS101953; HSS101954; HSS101955) were obtained from Invitrogen. The siRNA duplexes against AP1B1, AP2M2, AP3B2, AP3D1 and AP4M1 used in Figure S5C were from a siPerfect Membrane transporter Library (Sigma Genosys).
Yeast Two-Hybrid Screening
The Matchmaker System 3 and HEK293-derived cDNA library were purchased from Clontech. 
(D) GST pull-down assay with the GST-fused proteins (GST-AP3D-Y27N or
GST-AP3D-Y27C) and in vitro synthesized JCV agnoproteins (WT, K9Q). After incubation with in vitro synthesized JCV agnoproteins, the GST fusion proteins were precipitated with glutathione-sepharose and beads-bound proteins were subjected to immunoblot analysis with anti-agnoprotein Ab. The aliquots from mixtures before a pull-down experiment were also subjected to immunoblot analysis as 10% input. (E) GST pull-down assay with the GST-AP3D-Y27C and in vitro synthesized the C-terminal hexahistidine (6 x His) tagged agnoproteins of JCV or BKV. After incubation with in vitro synthesized agnoproteins, the GST fusion proteins were precipitated with glutathione-sepharose and beads-bound proteins were subjected to immunoblot analysis with anti-His tag Ab. The aliquots from mixtures before pull-down experiment were also subjected to immunoblot analysis as 10% input. The collected samples were applied to SDS-PAGE and immunoblotting with the indicated antibodies.
Culture supernatants were concentrated 25 times by centrifugation. 
